Is Li-ESWT effective in diabetic patients with severe erectile dysfunction?

Area of Science:

• Urology
• Andrology
• Regenerative Medicine

Background:

• Erectile dysfunction (ED) is a common complication of diabetes mellitus.
• Low-intensity extracorporeal shockwave treatment (Li-ESWT) is explored as a noninvasive therapy for ED.
• Optimal patient selection and treatment protocols for Li-ESWT in ED remain unclear.

Purpose of the Study:

• To evaluate the efficacy of Li-ESWT in diabetic patients with severe ED (IIEF-5 scores 5-7).
• To assess Li-ESWT's impact on patients refractory to phosphodiesterase type 5 (PDE5) inhibitor therapy.

Main Methods:

• Sixty-three diabetic patients with severe ED and PDE5 inhibitor non-response were enrolled.
• Patients received Li-ESWT.
• Efficacy was assessed using the International Index of Erectile Function-5 (IIEF-5) and Erection Hardness Scale (EHS) scores.

Main Results:

• Mean IIEF-5 scores showed a non-significant increase from 5.29 to 5.56 (P > 0.05).
• Mean EHS scores showed a non-significant increase from 1.46 to 1.48 (P > 0.05).
• No significant improvement in erectile function was observed post-Li-ESWT.

Conclusions:

• Li-ESWT did not enhance the response to PDE5 inhibitors in this cohort.
• The study suggests Li-ESWT is not effective for severe ED in diabetic patients unresponsive to PDE5 inhibitors.
• Further investigation into Li-ESWT protocols and patient selection for diabetic ED is warranted.